As of January 2026 Inozyme Pharma has a market cap of A$0.38 Billion. This makes Inozyme Pharma the world's 8190th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.